Smart Pills Patient Monitoring Market Analysis by Target Area (Esophagus, Stomach, Small Intestine, and Large Intestine); by Application (Capsule Endoscopy, Patient Monitoring, and Drug Delivery); by Disease Indication (Small Bowel Tumors, Celiac Disease, Inherited Polyposis Syndromes, Neurological Disorders, Crohn's Disease, Occult GI Bleeding, and Others); and by End-User (Hospitals, Specialty Clinics, and Others) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2035

  • Report ID: 3864
  • Published Date: Mar 01, 2023
  • Report Format: PDF, PPT

Companies Dominating the Smart Pills Patient Monitoring Landscape

top-features-companies

    AbbVie Inc

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • AbbVie Inc., announced a strategic collaboration with HotSpot Therapeutics Inc. to expand its immunology pipeline. This collaboration is estimated to lead to the development of the first and only small molecule inhibitor of IRF5 (interferon regulatory factor 5) intended for the treatment of autoimmune diseases using HotSpot's Smart Allostery drug discovery platform.

  • etectRx, to partner up with Pear Therapeutics, to make wireless sensors embedded in medications. Through the collaboration, both companies intend to develop further products combining medication adherence data with digital therapeutics.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3864
  • Published Date: Mar 01, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing ratio of various types of chronic disorders, rising prevalence of gastrointestinal reflux disease (GERD), and worldwide increase in neurological disorders are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 16% over the forecast period, i.e., 2023-2035.

High cost of smart pills, stringent government regulations about the use of smart pills, and technical incompetence of smart pills in some disorders are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Medtronic plc, AbbVie Inc., Novartis AG, CapsoVision, Inc., Medimetrics, SA de CV, TauRx Pharmaceuticals Ltd, Otsuka Pharmaceutical Co. Ltd., FUJIFILM Holdings Corporation, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by target area, application, disease indication, end-user, and by region.

The capsule endoscopy segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying